5-172683427-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_001142651.3(NEURL1B):āc.586T>Gā(p.Phe196Val) variant causes a missense change. The variant allele was found at a frequency of 0.0000528 in 1,402,690 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000066 ( 0 hom., cov: 32)
Exomes š: 0.000051 ( 0 hom. )
Consequence
NEURL1B
NM_001142651.3 missense
NM_001142651.3 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: 5.22
Genes affected
NEURL1B (HGNC:35422): (neuralized E3 ubiquitin protein ligase 1B) Predicted to enable ubiquitin protein ligase activity. Predicted to be involved in ubiquitin-dependent endocytosis. Located in actin cytoskeleton and cytosol. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0612998).
BS2
High AC in GnomAd4 at 10 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NEURL1B | NM_001142651.3 | c.586T>G | p.Phe196Val | missense_variant | 3/5 | ENST00000369800.6 | NP_001136123.1 | |
NEURL1B | NM_001308177.2 | c.40T>G | p.Phe14Val | missense_variant | 2/4 | NP_001295106.1 | ||
NEURL1B | NM_001308178.2 | c.578-2744T>G | intron_variant | NP_001295107.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NEURL1B | ENST00000369800.6 | c.586T>G | p.Phe196Val | missense_variant | 3/5 | 1 | NM_001142651.3 | ENSP00000358815.5 | ||
NEURL1B | ENST00000522853.5 | c.40T>G | p.Phe14Val | missense_variant | 2/4 | 1 | ENSP00000430001.1 | |||
NEURL1B | ENST00000520919.5 | c.578-2744T>G | intron_variant | 1 | ENSP00000429797.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 152084Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
10
AN:
152084
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000778 AC: 4AN: 51394Hom.: 0 AF XY: 0.0000342 AC XY: 1AN XY: 29212
GnomAD3 exomes
AF:
AC:
4
AN:
51394
Hom.:
AF XY:
AC XY:
1
AN XY:
29212
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000512 AC: 64AN: 1250606Hom.: 0 Cov.: 30 AF XY: 0.0000523 AC XY: 32AN XY: 611504
GnomAD4 exome
AF:
AC:
64
AN:
1250606
Hom.:
Cov.:
30
AF XY:
AC XY:
32
AN XY:
611504
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000658 AC: 10AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74296
GnomAD4 genome
AF:
AC:
10
AN:
152084
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
74296
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2021 | The c.586T>G (p.F196V) alteration is located in exon 3 (coding exon 3) of the NEURL1B gene. This alteration results from a T to G substitution at nucleotide position 586, causing the phenylalanine (F) at amino acid position 196 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;N
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Pathogenic
D;T
Sift4G
Uncertain
D;T
Polyphen
0.043
.;B
Vest4
MutPred
0.44
.;Loss of stability (P = 0.0727);
MVP
MPC
0.73
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at